India's Jubilant Completes Acquisition of U.S. Co Hollister-Stier (India)
This article was originally published in PharmAsia News
Jubilant Organosys, a pharmaceutical research company in India, has finalized the purchase of U.S.-based Hollister-Stier Laboratories for $122.5 million in an all-cash transaction. Jubilant is looking to strengthen its growing global expertise in custom-research and manufacturing services. (Click here for more
You may also be interested in...
Buoyed chiefly by earnings from its foreign businesses, India's pharmaceuticals and chemicals major Jubilant Organosys reported a net profit of 4 billion rupees ($98 million) for the year ending March 31
NEW DELHI - India's growing success in the pharmaceutical custom research and manufacturing services sector is demonstrated by Jubilant Organosys netting CRAMS contracts totaling $92 million for 2008, with most contracts coming from Japan, China, the U.S. and Europe, the Uttar Pradesh-based manufacturer said Feb. 2
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.